Fast Five Quiz: Early Non–Small Cell Lung Cancer

Daniel S. Schwartz, MD


May 24, 2022

Non–small cell lung cancer (NSCLC) accounts for 80%-85% of all lung cancers and nearly 25% of all cancer deaths, with adenocarcinoma, the predominant subtype. Patients with NSCLC often have no symptoms, and unfortunately often present initially with advanced disease, with only 20% of lung cancers presenting with localized disease. Thus, early detection through lung cancer screening in asymptomatic high-risk patients can offer a vital opportunity for early detection at an early stage with decreased mortality. Current recommendations include lung cancer screening using low-dose computed tomography for high-risk asymptomatic patients. The recommendations are on the basis of a regression risk model developed by the National Lung Screening Trial (NLST) Lung Screening Study (LSS) data and validated by NLST American College of Radiology Imaging Network data. The most common treatments for lung cancer include surgery, chemotherapy, radiation therapy, and/or targeted therapy, in combination or by themselves.

Are you up-to-date on early NSCLC? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.